Yield10 Bioscience Announces Fourth Quarter and Full Year 2017 Financial Results
March 08, 2018 16:04 ET
|
Yield10 Bioscience, Inc.
WOBURN, Mass., March 08, 2018 (GLOBE NEWSWIRE) -- Yield10 Bioscience, Inc. (NASDAQ:YTEN), a Company developing new technologies to achieve step-change improvements in crop yield to enhance global...
Yield10 Bioscience to Host Webcast of its 2017 Year-end Conference Call
February 28, 2018 08:30 ET
|
Yield10 Bioscience, Inc.
WOBURN, Mass., Feb. 28, 2018 (GLOBE NEWSWIRE) -- Yield10 Bioscience,Inc. (NASDAQ:YTEN) announced today that the Company plans to release its fourth quarter and full year 2017 financial results and...
Yield10 Bioscience Reports Encouraging Results from 2017 Field Tests of Novel Yield Trait Gene C3003 in Camelina and Canola
January 09, 2018 08:30 ET
|
Yield10 Bioscience, Inc.
WOBURN, Mass., Jan. 09, 2018 (GLOBE NEWSWIRE) -- Yield10 Bioscience, Inc. (NASDAQ:YTEN) today reported encouraging results from the 2017 Field Tests of its novel yield trait gene C3003 in Camelina...
Yield10 Bioscience Announces Closing of $14.5 Million Public Offering
December 21, 2017 13:00 ET
|
Yield10 Bioscience, Inc.
WOBURN, Mass., Dec. 21, 2017 (GLOBE NEWSWIRE) -- Yield10 Bioscience, Inc. (NASDAQ:YTEN) today announced the closing of an underwritten public offering of units for gross proceeds of $14.5 million,...
Yield10 Bioscience Grants Research License to Monsanto to Evaluate Two Novel Yield Traits in Soybean
December 11, 2017 08:00 ET
|
Yield10 Bioscience, Inc.
WOBURN, Mass., Dec. 11, 2017 (GLOBE NEWSWIRE) -- Yield10 Bioscience, Inc. (NASDAQ:YTEN) announced today that it has granted a non-exclusive research license to Monsanto Company to evaluate its novel...
Yield10 Bioscience CSO Dr. Kristi Snell to Present at CanolaWeek 2017
December 07, 2017 08:30 ET
|
Yield10 Bioscience, Inc.
WOBURN, Mass., Dec. 07, 2017 (GLOBE NEWSWIRE) -- Yield10 Bioscience, Inc. (NASDAQ:YTEN) announced that CSO Kristi Snell, Ph.D., will be presenting today on a panel being held at the CanolaWeek 2017...
Yield10 Bioscience Announces Adjournment of Special Meeting of Stockholders
November 29, 2017 10:30 ET
|
Yield10 Bioscience, Inc.
WOBURN, Mass., Nov. 29, 2017 (GLOBE NEWSWIRE) -- Yield10 Bioscience, Inc. (NASDAQ:YTEN) announced today that the Special Meeting of Stockholders scheduled for today to vote on a proposal to decrease...
Yield10 Bioscience Announces Third Quarter 2017 Financial Results
November 09, 2017 16:03 ET
|
Yield10 Bioscience, Inc.
WOBURN, Mass., Nov. 09, 2017 (GLOBE NEWSWIRE) -- Yield10 Bioscience, Inc. (NASDAQ:YTEN) today reported financial results for the three and nine months ended September 30, 2017. “Over the course of...
Yield10 Bioscience Obtains Confirmation of Nonregulated Status from USDA-APHIS for its Genome-edited Camelina Line
September 05, 2017 08:35 ET
|
Yield10 Bioscience, Inc.
WOBURN, Mass., Sept. 05, 2017 (GLOBE NEWSWIRE) -- Yield10 Bioscience, Inc. (NASDAQ:YTEN) announced today that it has received a positive response from USDA-APHIS’s Biotechnology Regulatory Services...
Yield10 Bioscience Announces Collaboration with National Research Council of Canada to Improve Yield and Drought Tolerance in Wheat
August 08, 2017 09:00 ET
|
Yield10 Bioscience, Inc.
WOBURN, Mass., Aug. 08, 2017 (GLOBE NEWSWIRE) -- Yield10 Bioscience, Inc. (NASDAQ:YTEN) announced today that its wholly owned Canadian subsidiary, Metabolix Oilseeds, Inc., has signed a...